Invention Grant
- Patent Title: Nucleic acids encoding and methods of producing proteins comprising antibody chains
-
Application No.: US17855510Application Date: 2022-06-30
-
Publication No.: US12202907B2Publication Date: 2025-01-21
- Inventor: Stéphanie Chanteux , Laurent Gauthier , Nicolas Gourdin , Carine Paturel , Ivan Perrot , Benjamin Rossi
- Applicant: Innate Pharma , Orega Biotech
- Applicant Address: FR Marseilles; FR Ecully
- Assignee: Innate Pharma,Orega Biotech
- Current Assignee: Innate Pharma,Orega Biotech
- Current Assignee Address: FR Marseilles; FR Ecully
- Agency: Knobbe, Martens, Olson & Bear, LLP
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61P35/00 ; G01N33/574
Abstract:
The present invention relates to antigen-binding compounds that inhibit the enzymatic activity of soluble human CD39. The invention also relates to cells producing such compounds; methods of making such compounds, and antibodies, fragments, variants, and derivatives thereof; pharmaceutical compositions comprising the same; methods of using the compounds to diagnose, treat or prevent diseases, e.g., cancer.
Public/Granted literature
- US20230025732A1 COMPOSITIONS AND METHODS FOR TREATING CANCER Public/Granted day:2023-01-26
Information query
